Decision Criteria for Partial Nationalization of Pharmaceutical Supply Chain: A Scoping Review

(1) Background: Any disturbance in the pharmaceutical supply chain (PSC) can disrupt of medicines and affect efficiency health systems. Due to shortages global pharma over past few years complex nature free trade its limitations when confronted by a major humanitarian crisis, many countries have taken steps mitigate risks disruption, including, for example, recommending adoption plus one diversification approach, increasing safety stock, nationalizing medical chains. (2) Objective: To scope findings academic literature related decision criteria guide national policy decisions “Partial Nationalization Pharmaceutical Supply Chain” (PNPSC) from viewpoints three main stakeholders: industry, payers (government insurance), patients. (3) Methods: These consist scoping review peer-reviewed literature. (4) Results: A total 115 studies were included. For local manufacturing decisions, five 15 sub-criteria identified. Weighting, decision-making, risk assessment, forecasting data analysis tools applied; (5) Conclusions: The could serve as baseline constructing PNPSC frameworks after careful adaptation context.